The global coagulation analyzers market is expected to reach USD 3.58 billion by 2019, growing at a CAGR of 8.3 percent from 2014 to 2019. Among clinical laboratory segment, the consumables segment is expected to grow at the highest CAGR in the forecast period, as per MarketsandMarkets.
A number of factors including the development of high-throughput hemostasis analyzers, increasing adoption of automated hemostasis instruments by diagnostic laboratories, technological advancements, and developments in high-sensitivity point-of-care (POC) hemostasis testing are propelling the growth of the global coagulation analyzers market. On the other hand, slow adoption of advanced hemostasis instruments in emerging economies, and high cost of coagulation analyzers are restricting the growth of the global coagulation analyzers market.
The market is dominated by North America, followed by Europe, Asia-Pacific, and the rest of the world (RoW). Asia-Pacific is likely to witness the highest growth in this market due to developing healthcare infrastructure. Increasing funding/investments toward the development of hemostasis products and growing focus of both international and domestic players on emerging countries are stimulating the growth of coagulation analyzers and reagents market in this region.